Recent innovations and advances in arteriovenous fistula creation: A narrative review
Vascular Investigation and Therapy · 2025-01 · 8 (1) · 7-17
DOI: 10.4103/vit.vit_2_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Investigation and Therapy, online erschienen am 30.04.2025. Verfasst von Cayetana Lazcano-Etchebarne und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, Connecticut, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Arteriovenous fistulae (AVF) are the gold standard for vascular access among patients requiring hemodialysis; however, AVF have high primary failure rates. Novel approaches and technologies to improve AVF patency include modifications to open approaches, such as the radial artery deviation and reimplantation fistula, and percutaneous approaches, such as the endovascular AVF. Despite these advances, these modifications are limited in reducing neointimal hyperplasia (NIH), stenosis, or thrombosis and thus have limited capacity to improve AVF maturation and utilization; as such, vascular access requires continued innovation. Emerging strategies to prevent NIH include drug-embedded and bioresorbable perivascular wraps. Increased rates of AVF failure among women highlight sex differences in the biology of AVF maturation and suggest additional targets to improve outcomes. Other advances in understanding the biology of AVF maturation suggest potentialized approaches for patients, including immune system modulation and stem cell therapies. Although these emerging technologies may improve AVF maturation and utilization, long-term patency and freedom from complications such as central vein stenosis and dialysis access associated distal ischemia emphasize the critical need for continued scientific inquiry and technological development to optimize vascular access.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, Connecticut, United States.
- Ponce Health Sciences University School of Medicine, Ponce, Puerto Rico.
- Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States.
- Surgical Service, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States.
- Centre Hospitalier Universitaire de Nice, Department of Vascular Surgery, 06000 Nice, France.
- Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, United States.
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Lazcano-Etchebarne, C., Aboian, E., Strosberg, D., Sadaghianloo, N., Schwartz, A. W., Ho, B., Ohashi, Y., Kano, M., Gonzalez, L., Bai, H., & Dardik, A. (2025). Recent innovations and advances in arteriovenous fistula creation: A narrative review. Vascular Investigation and Therapy, 8(1), 7-17. https://doi.org/10.4103/vit.vit_2_25
Vancouver
Lazcano-Etchebarne C, Aboian E, Strosberg D, Sadaghianloo N, Schwartz AW, Ho B, et al. Recent innovations and advances in arteriovenous fistula creation: A narrative review. Vascular Investigation and Therapy. 2025;8(1):7-17. doi:10.4103/vit.vit_2_25
BibTeX
@article{LazcanoEtchebarne2025,
author = {Lazcano-Etchebarne, Cayetana and Aboian, Edouard and Strosberg, David and Sadaghianloo, Nirvana and Schwartz, Andrew W and Ho, Bryan and Ohashi, Yuichi and Kano, Masaki and Gonzalez, Luis and Bai, Hualong and Dardik, Alan},
title = {Recent innovations and advances in arteriovenous fistula creation: A narrative review},
journal = {Vascular Investigation and Therapy},
year = {2025},
volume = {8},
number = {1},
pages = {7--17},
doi = {10.4103/vit.vit_2_25}
}
EUVIMED